In a recent study published in the journal Cell, researchers investigated the infectivity, fusogenicity, and immune evasive potential of two novel Omicron subvariants – BA.2.86 and FLip. They used ...

Official COVID-19 case metrics severely undercount the true number of infections, leaving the United States with a critical blind spot as the most transmissible coronavirus variant yet takes hold. The ...

Another vaccine trial is underway— this time for an omicron-specific vaccine dose. “The virus can evolve very rapidly and I think the RNA approach is probably the only vaccine approach that can adapt ...

The newly updated CDC guidelines don't require testing at the end of isolation because PCR tests can stay positive for up to 12 weeks, CDC Director Dr. Rochelle Walensky told "Good Morning America" on ...

FILE PHOTO: Logo of Swiss drugmaker Roche is seen in Basel ZURICH (Reuters) - Roche has launched a new PCR test to detect a fast-spreading sub-variant of the Omicron variant of Coronavirus, the Swiss ...

Thea van de Mortel teaches into the Griffith University Master of Infection Prevention and Control program. You’ve tested negative for COVID using a rapid antigen test (RAT), but are a close contact ...

Labs at Seattle-based University of Washington Medicine are gearing up to test the COVID-19 omicron variant against current vaccines and natural immunity to other strains, according to a Nov. 29 ...

The omicron variant of SARS-CoV-2 is much less likely to lead to long Covid than the variant circulating at the start of the COVID-19 pandemic, new research being presented at this year's European ...

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) has launched COVID-19 PCR test which detects a fast spreading Omicron sub-variant XBB.1.5. The Swiss pharma giant said its subsidiary TIB Molbiol developed the test ...